Posttraumatic stress disorder with secondary psychotic features: neurobiological findings

Progress in Brain Research

Volumn 167, Issue , 2007, Pages 299-302

  Braakman, Mario H ^a   Kortmann, Frank A M ^a   van den Brink, Wim ^b   Verkes, Robbert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

corticotrophin releasing hormone (CRH); cortisol; dopamine beta hydroxylase (DbH); neurobiology; psychosis; PTSD; PTSD SP; smooth pursuit eye movement (SPEM)

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; DOPAMINE BETA MONOOXYGENASE; HYDROCORTISONE; PLACEBO; RISPERIDONE;

CLINICAL ASSESSMENT; CLINICAL TRIAL; CORTICOTROPIN BLOOD LEVEL; DISEASE CLASSIFICATION; EYE MOVEMENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; MEDICAL RESEARCH; NEUROBIOLOGY; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW;

BIOLOGICAL MARKERS; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE BETA-HYDROXYLASE; HUMANS; HYDROCORTISONE; PSYCHOTIC DISORDERS; PURSUIT, SMOOTH; STRESS DISORDERS, POST-TRAUMATIC;

EID: 36249019782     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)67027-7     Document Type: Review

References (9)

1. Braakman, M.H., Kortmann, F.A.M. and Brink, W.v.d. (submitted) Validity of 'posttraumatic stress disorder with psychotic features': a review of the evidence.
2. Cerbone A., Sautter F.J., Manguno-Mire G., Evans W.E., Tomlin H., Schwartz B., and Myers L. Differences in smooth pursuit eye movement between posttraumatic stress disorder with secondary psychotic symptoms and schizophrenia. Schizophr. Res. 63 (2003) 59-62
3. Cubells J.F., and Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology 174 (2004) 463-476
4. Hamner M.B., Faldowski R.A., Ulmer H.G., Frueh B.C., Huber M.G., and Arana G.W. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int. Clin. Psychopharmacol. 18 (2003) 1-8
5. Hamner M.B., and Gold P.B. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res. 77 (1998) 175-181
6. Manguno-Mire, G.M., Sautter, F.J., Johnson, J.E., Myers, L., Bryan, F., Nenov, N., Ross, R., Bissette, G. and O'Neill, P. (in prep.) Cortisol response to dexamethasone in PTSD patients with psychotic symptoms.
7. Nelson J.C., and Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 154 (1997) 1497-1503
8. Sautter F.J., Bissette G., Wiley J., Manguno-Mire G., Schoenbachler B., Myers L., Johnson J.E., Cerbone A., and Malaspina D. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol. Psychiatry 54 (2003) 1382-1388
9. Thaker G.K., Avila M.T., Hong E.L., Medoff D.R., Ross D.E., and Adami H.M. A model of smooth pursuit eye movement deficit associated with the schizophrenia phenotype. Psychophysiology 40 (2003) 277-284